Close

Mela Sciences (MELA) Confirms CE Mark Approval for MelaFind(R)

September 6, 2011 4:53 PM EDT
Mela Sciences (Nasdaq: MELA) has confirmed it has received CE Mark approval for MelaFind, allowing the company to market its MelaFind device to dermatologists across the EU. The company intends to initially market MelaFind in Germany, which has the highest incidence of melanoma in Europe.

Joseph Gulfo, President and CEO of Mela, said, "We're extremely pleased to receive the CE Mark for MelaFind. With more than 81 million people, Germany represents a significant opportunity for the company and an ideal market to launch MelaFind in the EU. Given the high rates of melanoma seen in the German population, we believe MelaFind has the potential to make a deep impact on the disease there. In order to achieve our initial goals for the commercial development phase of the launch, we plan to utilize a direct sales force that will focus on strategically placing MelaFind systems in the top dermatology practices in several key cities throughout the country."


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News